| 1 |
Expression of CXCL1 in human endothelial cells induces angiogenesis through the CXCR2 receptor and the ERK1/2 and EGF pathways
Makito Miyake, Steve Goodison, Virginia Urquidi et al. · Laboratory Investigation
Open access |
3 Jun 2013 |
150 |
| 2 |
A Multi-Analyte Assay for the Non-Invasive Detection of Bladder Cancer
Steve Goodison, Myron N. Chang, Yunfeng E. Dai et al. · PLoS ONE
Open access |
19 Oct 2012 |
109 |
| 3 |
Angiogenin promotes tumoral growth and angiogenesis by regulating matrix metallopeptidase-2 expression via the ERK1/2 pathway
Makito Miyake, Steve Goodison, Adrienne Lawton et al. · Oncogene
Open access |
24 Feb 2014 |
105 |
| 4 |
Matrix metalloproteinase-10 promotes tumor progression through regulation of angiogenic and apoptotic pathways in cervical tumors
Ge Zhang, Makito Miyake, Adrienne Lawton et al. · BMC Cancer
Open access |
3 May 2014 |
99 |
| 5 |
Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors
Rocio García‐Carbonero et al. · Journal for ImmunoTherapy of Cancer
Open access |
Mar 2022 |
92 |
| 6 |
CCL18 in a Multiplex Urine-Based Assay for the Detection of Bladder Cancer
Virginia Urquidi, Jeong-Soon Kim, Myron N. Chang et al. · PLoS ONE
Open access |
21 May 2012 |
85 |
| 7 |
Urinary Protein Biomarker Panel for the Detection of Recurrent Bladder Cancer
Charles Joel Rosser, Myron N. Chang, Yunfeng E. Dai et al. · Cancer Epidemiology Biomarkers & Prevention
Open access |
9 Apr 2014 |
73 |
| 8 |
Targeting Plasminogen Activator Inhibitor-1 Inhibits Angiogenesis and Tumor Growth in a Human Cancer Xenograft Model
Evan Gomes-Giacoia, Makito Miyake, Steve Goodison et al. · Molecular Cancer Therapeutics
Open access |
26 Sep 2013 |
72 |
| 9 |
Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers
Makito Miyake, Adrienne Lawton, Steve Goodison et al. · BMC Cancer
Open access |
Jul 2013 |
69 |
| 10 |
A microRNA biomarker panel for the non-invasive detection of bladder cancer
Virginia Urquidi, Mandy Netherton, Evan Gomes-Giacoia et al. · Oncotarget
Open access |
16 Nov 2016 |
68 |
| 11 |
External Validation of a Multiplex Urinary Protein Panel for the Detection of Bladder Cancer in a Multicenter Cohort
Li-Mei Chen et al. · Cancer Epidemiology Biomarkers & Prevention
Open access |
12 Jun 2014 |
68 |
| 12 |
Multiplex Protein Signature for the Detection of Bladder Cancer in Voided Urine Samples
Charles Joel Rosser, Shanti Ross, Myron N. Chang et al. · The Journal of Urology
Open access |
11 Jun 2013 |
63 |
| 13 |
PAI-1 Leads to G1-Phase Cell-Cycle Progression through Cyclin D3/cdk4/6 Upregulation
Evan Gomes Giacoia, Makito Miyake, Adrienne Lawton et al. · Molecular Cancer Research
Open access |
24 Jan 2014 |
60 |
| 14 |
Diagnostic performance of Oncuria™, a urinalysis test for bladder cancer
Yosuke Hirasawa, Ian Pagano, Runpu Chen et al. · Journal of Translational Medicine
Open access |
6 Apr 2021 |
55 |
| 15 |
Chemokine (C-X-C motif) ligand 1 (CXCL1) protein expression is increased in high-grade prostate cancer
Makito Miyake, Adrienne Lawton, Steve Goodison et al. · Pathology - Research and Practice
|
28 Oct 2013 |
54 |
| 16 |
Monoclonal Antibody against CXCL1 (HL2401) as a Novel Agent in Suppressing IL6 Expression and Tumoral Growth
Makito Miyake, Hideki Furuya, Sayuri Onishi et al. · Theranostics
Open access |
2019 |
48 |
| 17 |
A multiplex immunoassay for the non-invasive detection of bladder cancer
Yoshiko Shimizu, Hideki Furuya, Peter Bryant Greenwood et al. · Journal of Translational Medicine
Open access |
30 Jan 2016 |
48 |
| 18 |
Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signature
Ge Zhang, Evan Gomes-Giacoia, Yunfeng E. Dai et al. · Diagnostic Pathology
Open access |
11 Nov 2014 |
48 |
| 19 |
Prognostic cancer gene signatures share common regulatory motifs
Ying Wang, Steve Goodison, Xiaoman Li et al. · Scientific Reports
Open access |
30 Jun 2017 |
36 |
| 20 |
Investigation of CCL18 and A1AT as potential urinary biomarkers for bladder cancer detection
Makito Miyake, Shanti Ross, Adrienne Lawton et al. · BMC Urology
Open access |
5 Sep 2013 |
35 |
| 21 |
Erythropoietin is a JAK2 and ERK1/2 effector that can promote renal tumor cell proliferation under hypoxic conditions
Makito Miyake, Steve Goodison, Adrienne Lawton et al. · Journal of Hematology & Oncology
Open access |
3 Sep 2013 |
33 |
| 22 |
Simultaneous multi-analyte urinary protein assay for bladder cancer detection
Charles Joel Rosser, Yunfeng E. Dai, Makito Miyake et al. · BMC Biotechnology
Open access |
Apr 2014 |
32 |
| 23 |
Analytical validation of ONCURIA™ a multiplex bead-based immunoassay for the non-invasive bladder cancer detection
Hideki Furuya, Lindlelyn Tabula, Riko Lee et al. · Practical Laboratory Medicine
Open access |
Nov 2020 |
29 |
| 24 |
Urinary Biomarkers of Bladder Cancer: An Update and Future Perspectives
Charles Joel Rosser, Virginia Urquidi, Steve Goodison · Biomarkers in Medicine
Open access |
17 Sep 2013 |
28 |
| 25 |
Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer
Norihiko Masuda, Osamu Ogawa, Meyeon Park et al. · Oncotarget
ReviewOpen access |
3 Jan 2018 |
27 |
| 26 |
Application of a multiplex urinalysis test for the prediction of intravesical BCG treatment response: A pilot study
Kaoru Murakami, Ashish M. Kamat, Yunfeng Dai et al. · Cancer Biomarkers
Open access |
7 Sep 2021 |
21 |
| 27 |
Clinical implications in the shift of syndecan-1 expression from the cell membrane to the cytoplasm in bladder cancer
Makito Miyake, Adrienne Lawton, Yunfeng E. Dai et al. · BMC Cancer
Open access |
13 Feb 2014 |
20 |
| 28 |
A Nomogram Derived by Combination of Demographic and Biomarker Data Improves the Noninvasive Evaluation of Patients at Risk for Bladder Cancer
Sijia Huang, Lei Kou, Hideki Furuya et al. · Cancer Epidemiology Biomarkers & Prevention
Open access |
6 Jul 2016 |
12 |
| 29 |
Bladder cancer risk stratification with the Oncuria 10-plex bead-based urinalysis assay using three different Luminex xMAP instrumentation platforms
Hideki Furuya, Toru Sakatani, Sunao Tanaka et al. · Journal of Translational Medicine
Open access |
2 Jan 2024 |
11 |
| 30 |
Performance of the Oncuria-Detect bladder cancer test for evaluating patients presenting with haematuria: results from a real-world clinical setting
Ian Pagano, Zhen Zhang, Michael Luu et al. · Journal of Translational Medicine
Open access |
18 Jun 2025 |
9 |
| 31 |
Clinical Utility of Oncuria™, a Multiplexed Liquid Biopsy for the Non-Invasive Detection of Bladder Cancer—A Pilot Study
Kaoru Murakami, Ian Pagano, Hideki Furuya et al. · Diagnostics
Open access |
6 Jan 2022 |
9 |
| 32 |
Influencing Factors on the Oncuria™ Urinalysis Assay: An Experimental Model
Kaoru Murakami, Ian Pagano, Runpu Chen et al. · Diagnostics
Open access |
3 Jun 2021 |
7 |
| 33 |
Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid Tumors
Elliott Joseph Brea et al. · Cancer Immunology Research
Open access |
8 Sep 2025 |
4 |
| 34 |
A Diagnostic Gene Expression Signature for Bladder Cancer Can Stratify Cases into Prescribed Molecular Subtypes and Predict Outcome
Runpu Chen, Ian Pagano, Yijun Sun et al. · Diagnostics
Open access |
25 Jul 2022 |
4 |
| 35 |
Diagnostic Accuracy of the Oncuria-Detect Multiplex Immunoassay in Detecting Upper Tract Urothelial Carcinoma
Kazutoshi Fujita, Makito Miyake, Mamoru Hashimoto et al. · The Journal of Urology
Open access |
3 Oct 2025 |
2 |
| 36 |
Effects of Different Voided Urine Sample Storage Time, Temperature, and Preservatives on Analysis with Multiplex Bead-Based Oncuria Bladder Cancer Immunoassay
Sunao Tanaka, Kaoru Murakami, Toru Sakatani et al. · Diagnostics
Open access |
9 Jan 2025 |
2 |
| 37 |
Clinical Validation of a Multiplex Urine Biomarker Assay for Surveillance of Recurrent Bladder Cancer
Yair Lotan, Michael Luu, Menghan Liu et al. · Clinical Cancer Research
Open access |
2 Jul 2026 |
1 |
| 38 |
Development and analytical validation of a multiplex diagnostic qPCR-array as a potential application in predicting the response to neoadjuvant chemotherapy in muscle invasive bladder cancer
Toru Sakatani, Sunao Tanaka, Kaoru Murakami et al. · Translational Oncology
Open access |
10 Sep 2025 |
1 |
| 39 |
Prospective multicenter validation of a Urine-Based multiplex assay for risk stratification of patients presenting with gross hematuria
Yair Lotan, Amit Gupta, Makito Miyake et al. · JNCI Journal of the National Cancer Institute
Open access |
14 Aug 2026 |
0 |
| 40 |
Additional file 1 of Detection of bladder cancer in patients with microscopic hematuria using Oncuria-Detect: results of a prospective, multicenter international study
Yair Lotan et al. · Figshare
Open access |
9 May 2026 |
0 |
| 41 |
Additional file 2 of Detection of bladder cancer in patients with microscopic hematuria using Oncuria-Detect: results of a prospective, multicenter international study
Yair Lotan et al. · Figshare
Open access |
9 May 2026 |
0 |
| 42 |
Developing a prediction model in a large case-control study for the early detection of bladder cancer
Sunao Tanaka, Lynne Ross Wilkens, Loı̈c Le Marchand et al. · Journal of Translational Medicine
Open access |
5 Dec 2025 |
0 |
| 43 |
Expanded Performance Comparison of the Oncuria 10-Plex Bladder Cancer Urine Assay Using Three Different Luminex xMAP Instruments
Sunao Tanaka, Takuto Shimizu, Ian Pagano et al. · Diagnostics
Open access |
10 Jul 2025 |
0 |
| 44 |
Development and Analytical Validation of a Multiplex Diagnostic qPCR-Array for Predicting the Response to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer
Toru Sakatani, Sunao Tanaka, Kaoru Murakami et al. · Preprints.org
PreprintOpen access |
24 Apr 2025 |
0 |
| 45 |
Distribution and Functional Significance of KLF15 in Mouse Cerebellum
Dan Li, Shuijing Cao, Yanrong Chen et al. · Research Square
PreprintOpen access |
14 Jun 2024 |
0 |
| 46 |
Role of LOXL1 in conventional outflow function and behavior
Guorong Li, William M Johnson, Heather Schmitt et al. · Investigative Ophthalmology & Visual Science
Open access |
22 Jul 2019 |
0 |